In patients with acute MI, serum levels of FGF23 were associated with one-year mortality only in those patients who concomitantly presented with HF, whereas no associations were observed in MI patients without HF despite similar FGF23 serum levels at admission. This evidence concerns the gene FGF23 and hydrops fetalis.